Processes for making opioids including 14-hydroxycodeinone and 14-hydroxymorphinone
Improved processes for making opioid products having low impurity levels including making 14-hydroxycodeinone and 14-hydroxymorphinone from thebaine and oripavine, respectively.
1. A method of making a 14-hydroxycodeinone composition having reduced levels of 8,14-dihydroxy-7,8-dihydrocodeinone comprising the steps of:
a. oxidizing thebaine with a peroxyacid to form the 14-hydroxycodeinone composition;
b. adding an alcohol to the reaction mixture at or about upon completion of step a; and
c. treating the reaction mixture of step b with a mixture of ammonium hydroxide solution and water to yield the 14-hydroxycodeinone composition having reduced levels of 8,14-dihydroxy-7,8-dihydrocodeinone.
2. The method of claim 1 , further comprising that the oxidizing of step a is affected by
i. dissolving thebaine in a carboxylic acid to form a reaction mixture; and
ii. adding hydrogen peroxide to the reaction mixture to form a peroxyacid in situ.
3. The method of claim 1 , wherein the alcohol is selected from the group consisting of ethanol and propanol.
4. A method of making a 14-hydroxymorphinone composition comprising the steps of:
a. oxidizing the oripavine with a peroxyacid to form the 14-hydroxymorphinone composition;
b. adding an alcohol to the reaction mixture at or about upon completion of step a; and
c. treating the reaction mixture of step b with a mixture of ammonium hydroxide solution and water to yield the 14-hydroxymorphinone composition.
5. The method of claim 4 , further comprising that the oxidizing of step a is affected by
i. dissolving oripavine in a carboxylic acid to form a reaction mixture; and
ii. adding hydrogen peroxide to the reaction mixture to form a peroxyacid in situ.
6. The method of claim 5 , further comprising adding at least one strong acid to the reaction mixture.
7. The method of claim 5 , wherein step i further comprising an alcohol in addition to the carboxylic acid.
8. The method of claim 4 further comprising purifying the 14-hydroxymorphinone composition of step c.
9. The method of claim 1 wherein the 14-hydroxycodeinone composition contains less than about 1000 ppm 8β,14-dihydroxy-7,8-dihydrocodeinone and less than about 1000 ppm 8β,14-dihydroxy-7,8-dihydrocodeinone isomer.
10. The method of claim 2 , wherein the carboxylic acid is selected from the group consisting of formic acid, acetic acid and propionic acid.
11. The method of claim 2 , further comprising adding at least one strong acid to the reaction mixture.
12. The method of claim 11 , wherein the strong acid is selected from hydrochloric acid, sulphuric acid, phosphoric acid, methanesulfonic acid, trifluoroacetic acid or mixtures thereof.
13. The method of claim 2 , wherein step i further comprises an alcohol in addition to the carboxylic acid.
14. The method of claim 13 , wherein the alcohol is selected from the group consisting of methanol, ethanol, and propanol.
15. The method of claim 2 , further comprising purifying the 14-hydroxycodeinone composition of step c.
16. The method of claim 15 , wherein the purifying comprises reducing an amount of at least one of 8β,14-dihydroxy-7,8-dihydrocodeinone and 8β,14-dihydroxy-7,8-dihydrocodeinone isomer of the 8,14-dihydroxy-7,8-dihydrocodeinone in the 14-hydroxycodeinone composition.
17. The method of claim 16 , wherein the amount of 8β,14-dihydroxy-7,8-dihydrocodeinone is less than about 50 ppm and the amount of 8β,14-dihydroxy-7,8-dihydrocodeinone isomer is less than about 125 ppm in the 14-hydroxycodeinone composition.
18. The method of claim 15 , wherein the purifying comprises the steps of:
a. dissolving the yielded 14-hydroxycodeinone composition in dichloromethane to form a mixture;
b. distilling the mixture while adding an alcohol or acetonitrile to the mixture; and
c. cooling the mixture to crystallize at least a portion of the 14-hydroxycodeinone.
19. The method of claim 18 , wherein the alcohol is ethanol or methanol.
20. The method of claim 8 , wherein the purifying comprises the steps of:
a. dissolving the yielded 14-hydroxymorphinone composition in dichloromethane to form a mixture;
b. distilling the mixture while adding an alcohol or acetonitrile to the mixture; and
c. cooling the mixture to crystallize at least a portion of the 14-hydroxymorphinone.